Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, Mark Stevenson, Tony White, Michael Rowe

Greg Lucier, chairman and CEO of Invitrogen, will assume that same role following consummation of the firm’s merger with Applied Biosystems, expected to close in the fall. Mark Stevenson, currently president and COO of ABI, will retain that role in the merged company, which will keep the ABI name. Tony White, chairman, president, and CEO of ABI parent Applera, will serve as a consultant to ABI following the deal.

Gene Express has appointed Michael Rowe to be senior VP of global marketing.
Rowe formerly was director of cardiovascular marketing at Women First Healthcare, senior marketing director at Pfizer, director of global outcomes research and strategic marketing at Allergan, and manager of international marketing and marketing research at Warner-Lambert Company.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.